封面
市場調查報告書
商品編碼
1740967

醫療保健諮詢服務市場機會、成長動力、產業趨勢分析及 2025 - 2034 年預測

Healthcare Consulting Services Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034

出版日期: | 出版商: Global Market Insights Inc. | 英文 130 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2024年,全球醫療保健諮詢服務市場規模達280億美元,預計到2034年將以9.1%的複合年成長率成長,達到669億美元。這得歸功於醫療保健機構對最佳化營運、整合新技術和提升病患治療效果日益成長的需求。隨著全球醫療保健系統面臨提高效率、採用數位化解決方案和遵守監管要求的挑戰,對專業醫療保健諮詢服務的需求預計將大幅成長。

醫療保健諮詢服務市場 - IMG1

醫療保健產業持續的數位轉型、提升營運效率的需求、日益複雜的監管環境以及對以患者為中心的醫療服務的日益重視,是推動醫療保健諮詢服務需求成長的關鍵因素。包括醫院、保險公司和製藥公司在內的醫療保健機構正在尋求技術整合、營運最佳化、法規合規性和策略規劃等領域的專業知識。隨著醫療保健產業的不斷發展,顧問公司正在幫助這些機構應對複雜的挑戰,提供創新的解決方案,並確保其永續發展。

市場範圍
起始年份 2024
預測年份 2025-2034
起始值 280億美元
預測值 669億美元
複合年成長率 9.1%

根據服務類型,策略諮詢細分市場在2024年的估值為71億美元,預計成長勢頭強勁,到2034年將達到168億美元,複合年成長率達9%,這主要受多種因素驅動,包括技術的快速進步、患者人口結構的變化以及監管環境的不斷演變。此外,疫情後的復甦加速了醫療機構對創新解決方案的需求。策略諮詢公司正致力於開發新的框架和策略,以幫助醫療服務提供者應對這一動態環境。

根據最終用途,醫療保健諮詢服務市場中的醫療保健提供者細分市場在2024年佔了28.2%的佔有率。醫療保健提供者利用諮詢服務來改善患者護理、最佳化醫院管理並實現成本節約。顧問協助醫療保健提供者實施最佳實踐、採用新技術、改善營運工作流程並遵守法規變更。在該領域使用諮詢服務可確保提供者能夠適應不斷變化的醫療保健服務格局。

2024年,北美醫療保健諮詢服務市場佔據43.3%的市場佔有率,這得益於市場對技術整合和營運諮詢服務的強勁需求。北美預計將主導醫療保健諮詢服務市場,這得益於其強大的醫療保健基礎設施、對數位醫療保健解決方案的持續投資以及對提高醫療保健服務效率的日益重視。美國在醫療保健創新領域處於領先地位,醫療保健提供者、保險公司和製藥公司正在增加對諮詢服務的投資,以改善醫療保健效果、降低成本並整合新技術。

全球醫療諮詢服務業的知名企業包括:普華永道、貝恩公司、Cognizant、麥肯錫公司、波士頓顧問集團、HURON、德勤、NTT DATA、奧緯諮詢、IQVIA、安永、艾意凱、埃森哲。為了鞏固市場地位,領先的顧問公司正在採取多項關鍵策略,包括與醫療服務提供者建立策略合作夥伴關係,以了解他們獨特的挑戰和需求。許多公司利用人工智慧和資料分析等先進技術,提供數據驅動的洞察,從而改善營運。此外,專注於醫療領域的利基市場,例如遠距醫療和數位健康解決方案,使他們能夠提供差異化服務。

目錄

第1章:方法論與範圍

第2章:執行摘要

第3章:行業洞察

  • 產業生態系統分析
  • 產業衝擊力
    • 成長動力
      • 醫療保健領域的技術進步
      • 併購活動增加
      • 全球研發支出不斷增加
    • 產業陷阱與挑戰
      • 隱性成本和營運動態
  • 成長潛力分析
  • 監管格局
  • 川普政府關稅
    • 對貿易的影響
      • 貿易量中斷
      • 報復措施
    • 對產業的影響
      • 供應方影響(原料)
        • 主要材料價格波動
        • 供應鏈重組
        • 生產成本影響
      • 需求面影響(售價)
        • 價格傳導至終端市場
        • 市佔率動態
        • 消費者反應模式
    • 受影響的主要公司
    • 策略產業反應
      • 供應鏈重組
      • 定價和產品策略
      • 政策參與
    • 展望與未來考慮
  • 技術格局
  • 未來市場趨勢
  • 波特的分析
  • PESTEL分析
  • 監管格局

第4章:競爭格局

  • 介紹
  • 公司矩陣分析
  • 公司市佔率分析
  • 主要市場參與者的競爭分析
  • 競爭定位矩陣
  • 策略儀表板

第5章:市場估計與預測:按服務類型,2021 - 2034 年

  • 主要趨勢
  • IT諮詢
  • 數位諮詢
  • 營運諮詢
  • 策略諮詢
  • 財務諮詢
  • 其他服務類型

第6章:市場估計與預測:依最終用途,2021 - 2034 年

  • 主要趨勢
  • 醫療保健提供者
  • 醫療保健付款人
  • 生命科學和製藥公司
  • 政府和監管機構
  • 醫療科技和數位健康公司

第7章:市場估計與預測:按地區,2021 - 2034 年

  • 主要趨勢
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 荷蘭
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第8章:公司簡介

  • Accenture
  • Bain & Company
  • BCG
  • Cognizant
  • Deloitte
  • EY
  • HURON
  • IQVIA
  • LEK
  • McKinsey & Company
  • NTT DATA
  • Oliver Wyman
  • PwC
簡介目錄
Product Code: 9947

The Global Healthcare Consulting Services Market was valued at USD 28 billion in 2024 and is estimated to grow at a CAGR of 9.1% to reach USD 66.9 billion by 2034, driven by the increasing demand for healthcare organizations to optimize operations, integrate new technologies, and enhance patient outcomes. As healthcare systems worldwide face the challenges of improving efficiency, adopting digital solutions, and complying with regulatory requirements, the need for specialized healthcare consulting services is expected to expand significantly.

Healthcare Consulting Services Market - IMG1

The ongoing digital transformation in the healthcare industry, the need to improve operational efficiencies, the rise in regulatory complexities, and the increasing focus on patient-centric care are key factors driving the demand for healthcare consulting services. Healthcare organizations, including hospitals, insurance companies, and pharmaceutical companies, are seeking expertise in areas such as technology integration, operational optimization, regulatory compliance, and strategic planning. As the healthcare sector continues to evolve, consulting firms are helping these organizations navigate complex challenges, providing innovative solutions, and ensuring sustainable growth.

Market Scope
Start Year2024
Forecast Year2025-2034
Start Value$28 Billion
Forecast Value$66.9 Billion
CAGR9.1%

Based on service type, the strategy consulting segment was valued at USD 7.1 billion in 2024, with projections indicating a strong growth trajectory, reaching USD 16.8 billion by 2034, reflecting a CAGR of 9% driven by multiple factors, including rapid technological advancements, changing patient demographics, and the evolving regulatory landscape. In addition, the post-pandemic recovery has accelerated the demand for innovative solutions within healthcare organizations. Strategy consulting firms are focusing on developing new frameworks and strategies to help healthcare providers navigate this dynamic environment.

Based on end use, the healthcare providers segment from the healthcare consulting services market held a 28.2% share in 2024. Healthcare providers use consulting services to improve patient care, optimize hospital administration, and achieve cost savings. Consultants assist healthcare providers in implementing best practices, adopting new technologies, improving operational workflows, and staying compliant with regulatory changes. The use of consulting services in this sector ensures that providers can adapt to the ever-changing landscape of healthcare delivery.

North America Healthcare Consulting Services Market held a 43.3% share in 2024, supported by strong market demand for technology integration and operational consulting services. North America is expected to dominate the healthcare consulting services market, driven by the robust healthcare infrastructure, ongoing investments in digital healthcare solutions, and an increasing focus on improving healthcare delivery efficiency. U.S. is a leader in healthcare innovation, with healthcare providers, insurers, and pharmaceutical companies increasingly investing in consulting services to improve healthcare outcomes, reduce costs, and integrate new technologies.

Prominent players in the Global Healthcare Consulting Services Industry include: PwC, Bain & Company, Cognizant, McKinsey & Company, BCG, HURON, Deloitte, NTT DATA, Oliver Wyman, IQVIA, EY, LEK, Accenture. To strengthen their market presence, leading consulting firms are adopting several key strategies. These include strategic partnerships with healthcare providers to understand their unique challenges and needs. Many firms leverage advanced technologies like artificial intelligence and data analytics to deliver data-driven insights for operational improvements. Additionally, focusing on niche markets within healthcare, such as telemedicine and digital health solutions, allows them to differentiate their services.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market scope and definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates and calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 3600 synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Technological advancements in the healthcare sector
      • 3.2.1.2 Increased mergers and acquisitions activity
      • 3.2.1.3 Rising global spending on research and development
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 Hidden costs and operational dynamics
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Trump administration tariffs
    • 3.5.1 Impact on trade
      • 3.5.1.1 Trade volume disruptions
      • 3.5.1.2 Retaliatory measures
    • 3.5.2 Impact on the Industry
      • 3.5.2.1 Supply-side impact (raw materials)
        • 3.5.2.1.1 Price volatility in key materials
        • 3.5.2.1.2 Supply chain restructuring
        • 3.5.2.1.3 Production cost implications
      • 3.5.2.2 Demand-side impact (selling price)
        • 3.5.2.2.1 Price transmission to end markets
        • 3.5.2.2.2 Market share dynamics
        • 3.5.2.2.3 Consumer response patterns
    • 3.5.3 Key companies impacted
    • 3.5.4 Strategic industry responses
      • 3.5.4.1 Supply chain reconfiguration
      • 3.5.4.2 Pricing and product strategies
      • 3.5.4.3 Policy engagement
    • 3.5.5 Outlook and future considerations
  • 3.6 Technology landscape
  • 3.7 Future market trends
  • 3.8 Porter's analysis
  • 3.9 PESTEL analysis
  • 3.10 Regulatory landscape

Chapter 4 Competitive Landscape, 2024

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Service Type, 2021 - 2034 ($ Mn)

  • 5.1 Key trends
  • 5.2 IT consulting
  • 5.3 Digital consulting
  • 5.4 Operations consulting
  • 5.5 Strategy consulting
  • 5.6 Financial consulting
  • 5.7 Other service types

Chapter 6 Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)

  • 6.1 Key trends
  • 6.2 Healthcare providers
  • 6.3 Healthcare payers
  • 6.4 Lifescience and pharma companies
  • 6.5 Government and regulatory agencies
  • 6.6 Healthcare technology and digital health companies

Chapter 7 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

  • 7.1 Key trends
  • 7.2 North America
    • 7.2.1 U.S.
    • 7.2.2 Canada
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 UK
    • 7.3.3 France
    • 7.3.4 Spain
    • 7.3.5 Italy
    • 7.3.6 Netherlands
  • 7.4 Asia Pacific
    • 7.4.1 China
    • 7.4.2 Japan
    • 7.4.3 India
    • 7.4.4 Australia
    • 7.4.5 South Korea
  • 7.5 Latin America
    • 7.5.1 Brazil
    • 7.5.2 Mexico
    • 7.5.3 Argentina
  • 7.6 Middle East and Africa
    • 7.6.1 South Africa
    • 7.6.2 Saudi Arabia
    • 7.6.3 UAE

Chapter 8 Company Profiles

  • 8.1 Accenture
  • 8.2 Bain & Company
  • 8.3 BCG
  • 8.4 Cognizant
  • 8.5 Deloitte
  • 8.6 EY
  • 8.7 HURON
  • 8.8 IQVIA
  • 8.9 LEK
  • 8.10 McKinsey & Company
  • 8.11 NTT DATA
  • 8.12 Oliver Wyman
  • 8.13 PwC